Surmounting the Challenges of Bispecific Antibody Characterization

Applications | 2021 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Overcoming the Challenges of Bispecific Antibody Characterization Using New Column Chemistries to Detect Product Impurities
Agilent BioHPLC Columns - Characterization of NIST Monoclonal Antibody Critical Quality Attributes - Application Compendium
Accelerate Your CQA Efficiency and Approach it with Multi-Attribute Methodology - Biopharma Compendium
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications